SavedAdd your journal

Journals / Kafkas Üniversitesi Veteriner Fakültesi Dergisi / 2013 / Cilt: 19 - Sayı: 1

Şap hastalıklı sığırlarda nitrik oksit düzeyi, total antioksidan ve oksidan kapasite

Nitric oxide levels, total antioxidant and oxidant capacity in cattle with foot-and-mouth-disease

KADİR BOZUKLUHAN
Emine ATAKİŞİ
Onur ATAKiŞİ
Pages
179–181
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was concluded that FMD increases serum NO levels and TOC, but do not affect TAC in cattle.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to investigate total antioxidant (TAC), oxidant capacity (TOC) and nitric oxide levels (NO) in cattle with foot-and-mouth-diseases (FMD).
📊
Key Findings & Data:Twenty Swiss Brown cattle aged between 24 and 48 months were used.
💡
Conclusion & Impact:It was concluded that FMD increases serum NO levels and TOC, but do not affect TAC in cattle.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:süt sığırı · antioksidanlar · kan kimyası

Abstract

The aim of this study was to investigate total antioxidant (TAC), oxidant capacity (TOC) and nitric oxide levels (NO) in cattle with foot-and-mouth-diseases (FMD). Twenty Swiss Brown cattle aged between 24 and 48 months were used. Animals were divided into two groups as control (n=10) and FMD (n=10). Blood samples were collected from jugular vein and centrifuged. TOC and NO levels were found to be significantly higher in FMD group compared to those of control group. However, no significant differences were present in TAC levels between FMD and control groups. It was concluded that FMD increases serum NO levels and TOC, but do not affect TAC in cattle.

Özet

Çalışmanın amacı şap hastalığına (FMD) yakalanmış sığırlarda total antioksidan (TAC), oksidan kapasite (TOC) ve nitrik oksit (NO) seviyelerini araştırmaktır. Araştırmada, yaşları 24 ve 48 ay arasında olan 20 Montofon ırkı sığır kullanıldı. Hayvanlar kontrol (n=10) ve şap hastalıklı (n=10) olmak üzere iki gruba ayrıldı. Kan örnekleri Vena jugularis’ ten alınarak santrifuj edildi. Şaplı hayvanlarda TOC ve NO seviyeleri kontrol grubundaki hayvanlara göre önemli düzeyde yüksekti. TAC seviyesinde ise şap hastalıklı ve kontrol grubu arasında önemli bir değişiklik saptanmadı. Sonuç olarak şap hastalığının sığırlarda serum NO ve TOC seviyesini artırırken, TAC seviyesini etkilemediği belirlendi.

🔖

Cite This Article

BOZUKLUHAN, K., ATAKİŞİ, E., ATAKiŞİ, O. (2013). Şap hastalıklı sığırlarda nitrik oksit düzeyi, total antioksidan ve oksidan kapasite. Kafkas Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 19 - Sayı: 1, 179–181. https://ajindex.com/articles/272965

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Lubroth J: Foot and mouth disease a review for the practitioner. Vet Clin Food Anim, 18, 475-499, 2002
  2. Tunca R, Sozmen M, Erdogan HM, Citil M, Uzlu E, Özen H, Gökce E: Determination of cardiac troponin I in the blood and heart of calves with foot mouth disease. J Vet Diagn Inves, 20, 598-605, 2008
  3. Yarım GF, Nisbet C, Cenesiz S, Coşkuner A: Şap hastalıklı koyunlarda serum nitrik oksit düzeyi ve adenozin deaminaz aktivitesinin araştırılması. Ankara Univ Vet Fak Derg, 53, 161-164, 2006
  4. Elitok B, Balıkçı E, Kececi H, Yılmaz K: Şaplı sığırlarda serum kreatinin fosfokinaz (CPK), laktat dehidrogenaz (LDH), aspartat aminotransferaz (AST) aktiviteleri, glukoz düzeyleri ve EKG bulguları. Kafkas Univ Vet Fak Derg, 5 (2): 161-166, 1999
  5. Gokce G, Gokce HI, Gunes V, Erdoğan HM, Citil M: Alterations in some haematological and biochemical parameters in cattle suffering from foot-and-mouth disease. Turk J Vet Anim Sci, 28 (4): 723-727, 2004
  6. Or ZS, Fidancı UR: Şap virusu ile enfekte ve aşılı danalarda serum proteinlerinin elektroforetik dağılımı. Ankara Univ Vet Fak Derg, 56, 13-18, 2009
  7. Şahal M, Imren HY, Ozlem MB, Tanyel B: Süt ineklerinde şap hastalığı ve diabetes mellitus arasındaki ilişki. Ankara Univ Vet Fak Derg, 41 (2): 169-181, 1994
  8. Stuer JD: Mammalian nitric oxide synthases. Biochim Biophys Acta, 41, 217-230, 1999
  9. Griffith OW: Nitric oxide synthase inhibitors: Mechanisms of action and in vivo studies. In, Weisman BA, Allon N, Shapira S (Eds): Biochemical, Pharmacological and Clinical Aspects of Nitric Oxide. pp. 21-36, Plenum Press, New York, 1995
  10. Groves JT, Wang C: Nitric oxide synthase: Models and mechanisms. Curr Opin Struct Biol, 4, 687-695, 2000
  11. Feldman PL, Stuehr DJ, Griffith OW: Mechanisms of mammalian nitric oxide biosynthesis. In, Weisman BA, Allon N, Shapira S (Eds): Biochemical, Pharmacological and Clinical Aspects of Nitric Oxide. pp. 14-20, Plenum Press, New York, 1995
  12. Akaike T, Noguchi Y, Ijiri S, Setoguchi K, Suga M, Zheng YM, Dietzschold B, Maeda H: Pathogenesis of influenza virus-induced pneumonia: Involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci USA, 93, 2448-2453, 1996
  13. James SL: Role of nitric oxide in parasitic infection. Microb Rev, 59, 533- 547, 1995
  14. Albina JE, Abate JA, Henry WL: Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation: Role of IFN-γ in the induction of the nitric oxide-